2011-10-03T13:55:10-04:00 2010-12-31 PricewaterhouseCoopers LLP 2001 MARKET ST SUITE 1700 PHILADELPHIA PA 19103 990 2010-01-01 237311318 DRUG INFORMATION ASSOCIATION INC DRUG 2154426100 800 ENTERPRISE ROAD HORSHAM PA 19044 Paul Pomerantz 2011-09-28 true 2673303000 2010 2016-03-07 17:11:31Z 29122615 false X WWW.DIAHOME.ORG X 1964 MD Attachment 1 18 18 110 3000 1058075 -12713 0 0 29569273 27580854 1872520 1335915 -90834 -11484 31350959 28905285 153111 139348 0 0 9636960 10768208 0 0 0 18933686 19698039 28723757 30605595 2627202 -1700310 28091343 24001291 11220725 8863428 16870618 15137863 X DIA FOSTERS INNOVATION TO IMPROVE HEALTH AND WELL BEING WORLDWIDE BY: PROVIDING INVALUABLE FORUMS TO EXCHANGE VITAL INFORMATION AND DISCUSS CURRENT ISSUES RELATED TO HEALTH PRODUCTS, TECHNOLOGIES, AND SERVICES; DELIVERING CUSTOMIZED LEARNING EXPERIENCES; BUILDING, MAINTAINING, AND FACILITATING TRUSTED RELATIONSHIPS WITH AND AMONG INDIVIDUALS AND ORGANIZATIONS THAT DRIVE AND SHARE DIA VALUES AND MANDATES; AND OFFERING A MULTIDISCIPLINARY NEUTRAL ENVIRONMENT, RESPECTED GLOBALLY FOR INTEGRITY AND RELEVANCY. false false 8853074 20363872 MEETINGs AND WORKSHOPS DIA provides a neutral global forum for the purpose of exchange and dissemination of information relevant to the professional education and development of its members. DIAs focus is on unbiased, patient-centric training for the worldwide medical community. DIA has grown to a global leadership position in professional education, beginning with traditional in-person events and expanding into technology-based, electronic learning media. The number of meetings and workshops held has increased from a total of two events held in the United States in 1980, to a total of 344 events held worldwide in 2010. In 2010, DIA conducted 202 workshops and training courses in the United States with over 10,970 participants. In addition to these events, the DIA Annual Meeting, the leading global conference on pharmaceutical information and education, attracted over 7,400 participants from the US and across the world. In 2010, DIA conducted 84 workshops and training courses across Europe, attracting over 3,500 participants. In addition, the Annual DIA Euro Meeting, which attracted approximately 2,500 participants, is recognized as one of the premier forums for exchange of information in the European medical/pharmaceutical community. In 2010, DIA conducted five educational events in Japan, attracting over 1,300 participants from Japan and other countries. In 2010 DIA conducted nine educational events in India, with participation exceeding 1,000 persons. In 2010, DIA conducted three events in China, including one educational workshop, and one annual meeting. Combined, these events attracted over 700 participants. In addition, DIA conducted one educational program events in Brazil, with participation of over 400 persons, one in South Africa with a participation of 255 and one in Korea with a participation of over 400. With an on-going commitment to internet technology-based learning, DIA continued to expand its global reach and advance its mission by offering various workshops in electronic webinar format. In 2010, DIA conducted 36 webinars, attracting over 100 individual and group participants. 2006802 3923560 TRAINING EXPENSE In 2010 DIA conducted 202 workshops and training courses in the United States with over 10,970 participants. In 2010, DIA consudcted 84 workshops and training courses across Europe, attracting over 3,500 participants. With an on-going commitment to internet technology-based learning, DIA continued to expand its global reach and advance its mission by offering various workshops in electronic webinar format. In 2010 DIA conducted 36 webinars, attracting over 100 individual and group participants. 1008646 66495 Publications First published in 1969, "Drug Information Journal" is a captive publication designed for the benefit of association members. It is published bi-monthly, in periodical form. All eligible members (approx. 18,000) receive the publication in electronic format. In addition, approximately 16,000 members receive a hard copy version as well. The "Drug Information Journal" is recognized as a leading source for the exchange of information concerning all aspects of drug development, regulation and utilization. It is regularly included in many major indices of scientific and medical literature. The "Global Forum" is the association's bi-monthly, 4-color magazine. The "Global Forum" presents important news from DIA conferences and workshops, volunteer reports, practical tips, regulatory and global updates, and upcoming DIA events. All eligible members receive both publications in alternating months throughout the year. 12431820 2167456 24300342 true false false false false false false false false true false false false true true false true false true true true false false false false false true true true false false false false false true true true false false false false true true true false false false true 86 0 true 110 true true true true JA SZ IN false false false false false false false false X 18 18 false true false false true true true true true false true true true true true true true true true true false X F ANDREW PEPITO 2154426126 800 ENTERPRISE RD STE 200 HORSHAM PA 19044 X MARIE A DRAY 5.0 X 0 0 0 MINNIE BAYLOR HENRY 10.0 X X 0 0 0 JEFFREY W SHERMAN 10.0 X X 0 0 0 RICHARD O DAY 10.0 X X 0 0 0 SERGIO GUERRERO 5.0 X 0 0 0 TATSUO KUROKAWA 5.0 X 0 0 0 THOMAS KUHLER 5.0 X 0 0 0 JOHN A ROBERT 5.0 X 0 0 0 STEPHEN A SONSTEIN 5.0 X 0 0 0 PER SPINDLER 5.0 X 0 0 0 TRUUS JANSE-DE HONG 5.0 X 0 0 0 SANDRA L KWEDER 5.0 X 0 0 0 JENNIFER L RIGGINS 5.0 X 0 0 0 LING SU 5.0 X 0 0 0 BEAT WIDLER 5.0 X 0 0 0 NANDKUMAR K CHODANKAR 5.0 X 0 0 0 DEBORAH DOLAN 5.0 X 0 0 0 JUDITH GLENNIE 5.0 X 0 0 0 Jean Yager 5.0 X 5600 0 0 STEVE CAFFEE 5.0 X 0 0 0 JUILLET YVES 10.0 X X 0 0 0 Paul Pomerantz 37.5 X 448050 0 38717 WILLIAM BRASSINGTON 37.5 X 109881 0 0 ANDREW PEPITO 37.5 X 94388 0 8055 CAROL LAYER 37.5 X 148985 0 22503 LISA ZOKS 37.5 X 201997 0 26219 LINDA TEMPLE 37.5 X 179154 0 20287 BRIGITTE FRANKE BRAY 37.5 X 294289 0 37453 CARLOS FULCHER 37.5 X 165415 0 13902 LORRAINE RISBOSKIN 37.5 X 126421 0 18863 MICHAEL ERNST 37.5 X 138267 0 18250 ANDREW HALLE 37.5 X 177714 0 6188 ARULSELVAM SELVARAJ 37.5 X 112001 0 27026 MICHAEL KELLER 37.5 X 110322 0 25975 2312484 0 263438 14 false true false Relevante Inc 1400 N Providence Road suite 4025 MEDIA PA 19063 Financial Consulting 694060 Liquidhub Inc 500 E Swedesford Road Suite 300 WAYNE PA 19087 Information Tech 595360 CADMUS PSG PO BOX 822934 PHILADELPHIA PA 19182 PUBLISHING SERVICES 516055 TMA RESOURCES INC 1919 GALLOWS ROAD SUITE 400 VIENNA VA 22182 IT CONSULTING 288585 AV EXPERIENCE INC NA 825-43 AVENUE LACHINE QUEBEC CA H8T2J6 AUDIO VISUAL SERVICE 280660 24 0 MEETINGS AND WORKSHOPS 611710 20363872 20363872 TRAINING 611710 3923560 3923560 PUBLICATIONS 900004 1130704 66495 1064209 MEMBERSHIP DUES 900099 2162718 2162718 27580854 1495316 1495316 0 0 41707 57929 -16222 -16222 -6134 -10088 159401 -159401 -159401 -159401 0 0 0 OTHER INCOME 4738 4738 4738 28905285 26521383 1058075 1325827 60549 60549 8856 8856 69943 69943 0 2007528 1505646 501882 0 6438304 4834248 1604056 685179 513884 171295 892842 671272 221570 744355 558266 186089 331759 286611 45148 240692 0 240692 95103 0 95103 0 0 0 0 581111 0 581111 273480 205110 68370 698082 523562 174520 0 566161 415741 150420 1111648 830778 280870 11832 11832 72749 0 72749 46353 34765 11588 0 556375 417281 139094 110643 82982 27661 MEETING AND WORKSHOP EXPENSE 8853074 8853074 0 0 TRAINING EXPENSE 2006802 2006802 0 0 PUBLICATION EXPENSE 1008646 1008646 0 0 FINANCIAL CONSULTING EXPENSE 587330 0 587330 0 IT CONSULTING 492568 336361 156207 0 2053631 1064133 989498 0 30605595 24300342 6305253 0 6546656 2679710 374455 394078 1974823 1385168 10368914 3633311 7097748 6735603 11746747 12581115 350914 225617 28091343 24001291 3108903 3094479 6285946 5762515 1808517 0 17359 6434 11220725 8863428 X 16870618 15137863 16870618 15137863 28091343 24001291 X -1700310 -32445 X false true true X false X 2261414 2260379 2222937 2258742 2162718 11166190 26312208 25564855 27751063 26063903 24287432 129979461 28573622 27825234 29974000 28322645 26450150 141145651 141145651 639928 1287331 680364 1883998 1495316 5986937 639928 1287331 680364 1883998 1495316 5986937 275000 4738 279738 29213550 29112565 30654364 30481643 27950204 147412326 0.95749 0.95588 0.04061 0.04225 X 2589372 2589372 5307660 1654819 3652841 118778 65787 52991 1879947 1604989 274958 473158 307716 165442 6735604 0 SECURITY DEPOSIT PAYABLE 6434 6434 28905285 30605595 -1700310 -32445 -32445 -1732755 29341594 436309 436309 28905285 28905285 31074349 468754 468754 30605595 30605595 Schedule D, PART XIII, LINE 2D subsidiaries expenses $410,825 Rental Expenses 57,929 -------- Total $468,754 ======== Schedule D, Part XII, LINE 2D Sudsidiaries Revenue $378,380 rental expenses 57,929 -------- Total $436,309 ======== Schedule D, PART XI, LINE 8 Equity loss of subsidiaries $-32,445 Schedule D, Part X SHOULD SETTLEMENT OF AN EXAMINATION OR OTHER EVENT RESULT IN A CHANGE IN MANAGEMENT'S EVALUATION OF A TAX POSITION TAKEN OR EXPECTED TO BE TAKEN IN FILINGS THAT HAVE NOT BEEN CLOSED BY STATUTE OR EXAMINATION, ANY ADDITIONAL INTEREST AND PENALTIES RELATED TO THE UNRECOGNIZED TAX BENEFIT AS A RESULT OF THE UNCERTAIN TAX POSITION WILL BE INCLUDED IN OPERATING EXPENSES. true Europe (Including Iceland and Greenland) 1 22 Program Services workshops & training 8678690 South Asia 1 5 Program Services workshops & training 224370 South Asia 1 Program Services workshops & training 966512 South Asia 1 3 Program Services workshops & training 605488 4 30 4 30 10475060 10475060 Europe/Iceland/Greenland Eurordis Summer School in Regulatory Affairs and Health Technology Assessment for Advanced Patient Advocates 35000 wire trans Europe/Iceland/Greenland Univestiy of Bonn -Drafting of a Table Guidance on Off Label Use for the ICH 34943 WIRE TRANS 2 false false true false false true Form 990, Schedule F, Part 1 Depending on the use of funds (e.g. educational programs, research, meeting attendance, etc..), each grantee is required to report to DIA management, on a regular schedule, the following: detailed program content documents; number of participants; ongoing relevance of subject matter to DIA's mission; actual vs. proposed timeline; proof of budgetary allocation to timeline; revised timeline for grant cycle; projected outcome of project; and a final report on the outcome of the project. true AMERICAN CANCER SOCIETY ASIAN INITIATIVES 41-60 MAIN STREET SUITE 307 FLUSHING NY 11355 200588190 501(C)(3) 5800 To support Cancer suppor group workshop to be conducted in Chinese for Chines Cancer patients UNIVERSITY OF MARYLAND PO BOX 41428 BALTIMORE MD 21203 526002033 501(C)(3) 24249 Health Literacy and Health Information-Seeking Behaviours of Cancer Patients in Ambulatory Health Care Settings REGENTS OF THE UNIVERSITY OF MINNESOTA NW 5957 PO BOX 1450 MINNEAPOLIS MN 55485 416007513 501(C)(3) 20500 Factors related to the success and failure of Designated Orphan Products DUKE CLINICAL RESEARCH INSTITUTE 300 WEST MORGAN ST SUITE 800 DURHAM NC 27701 560532129 501(C)(3) 10000 4th Annual Clinical Trials Networks Best Practices Study Coordinator Symposium 4 4 AWARDS 20 8856 FMV SCHEDULE I, PART 1, LINE 2 Depending on the use of funds (e.g. educational programs, research, meetinY attendance, etc..), each grantee is required to report to DIA management, on a regular schedule, the following: detailed program content documents; number of participants; ongoing relevance of subject matter to DIA's mission; actual vs. proposed timeline; proof of budgetary allocation to timeline; revised timeline for grant cycle; projected outcome of project; and a final report on the outcome of the project. X true true X X X X X true false false false false false false false false Paul Pomerantz 386250 0 61800 0 0 0 30822 0 7895 0 486767 0 0 0 CAROL LAYER 117257 0 31728 0 0 0 12550 0 9953 0 171488 0 0 0 LISA ZOKS 175122 0 26875 0 0 0 14517 0 11702 0 228216 0 0 0 LINDA TEMPLE 154231 0 24923 0 0 0 13779 0 6508 0 199441 0 0 0 MICHAEL ERNST 119601 0 18666 0 0 0 7321 0 10929 0 156517 0 0 0 BRIGITTE FRANKE BRAY 259892 0 34397 0 0 0 32311 0 5142 0 331742 0 0 0 ANDREW HALLE 142338 0 9283 0 26093 0 0 0 6188 0 183902 0 0 0 CARLOS FULCHER 140415 0 0 0 25000 0 13144 0 758 0 179317 0 0 0 Schedule J Part III Severance paid - Michael Ernst - $12,610; Andrew Halle - $26,093 WILLIAM BRASSINGTON CFO OF DIA & CEO OF 584179 CONTRACT ACCOUNTING AND false WILLIAM BRASSINGTON RELEVANTE, INC. MANAGEMENT SERVICES JONATHAN BRASSINGTON CEO OF LIQUID HUB & 595360 CONTRACT INFO TECH SERVICES false JONATHAN BRASSINGTON BROTHER OF WILLIAM JONATHAN BRASSINGTON BRASSINGTON FORM 990, PART IV, LINE 11F POLICIES The Worldwide Director of Finance (CFO), William Brassington, provided servies as an independent contractor for part of the year 2010. All of his time is billed to DIA through a THird-party professional services firm owned by him. The DIA China office is run by a separate, unrelated, third-party management company. Form 990, Part VI, Section A, Line 1a Two of the 20 board members listed on Part VII, Line 1a, Ling Su and Nandkumar Chodankar, are provisional advisory council members of the board. They serve as guests of the board in an advisory capacity but have no voting rights. During the year 2010, there were 18 voting members of the board. FORM 990, PART VI, SECTION A, LINE 6 The organization has members who pay dues but have no ownership interest in the organization. FORM 990, PART VI, SECTION A, LINE 7A Each member is entitled to one vote to elect directors, one vote to elect officers and one vote to change the by-laws of the organization. Service as officer and/or board director is on a volunteer basis. FORM 990, PART VI, SECTION A, LINE 7B Each member of the Board (the governing body) is duly elected by a proxy vote of the membership. The organization's by-laws define the duties, responsibilities and powers of the Board, including those actions subject to membership approval. FORM 990, PART VI, SECTION B, LINE 11A The draft 990 is reviewed jointly by the Executive Director, the CFO and the Finance Committee Chair. After this review is complete, a copy of the final return is provided to each sitting board member. After each board member receives a finished copy, the complete return is filed. FORM 990, PART VI, SECTION B, LINE 12C Periodically management evaluates all existing paid vendor relationships for goods and/or services. They assess the parties involved and the relationships between them and DIA. Where conflicts with standing policy may develop or exist, appropriate corrective actions are taken, up to and including replacement of the vendor with a suitable and qualified substitute that poses no conflict of interest. New vendors are evaluated to determine if potential conflicts exist before approval of any paid relationship is granted. FORM 990, PART VI, SECTION B, LINE 15A & 15B On a regular basis, but no less than biennially, the Compensation Committee of the Board of Directors evaluates the complete compensation programs of all key employees to ensure they are compliant with all applicable laws and consistent with the provisions of standing compensation policy. This includes salary, benefits, bonuses and other payments made to both senior management and all others deemed to be subject to compensation review. The results of the evaluation are presented to the Board of Directors in a formal, written Compensation report. FORM 990, PART VI, SECTION C, LINE 19 DIA's Form 990 and Form 990-T are available upon request. The form 990 is also available on Guidestar.com. The organization's bylaws are available to the public on its website. Conflict of interest policy and financial statements are not made available to the public. DRUG INFORMATION ASSOCIATION LLC 800 ENTERPRISE ROAD SUITE 200 HORSHAM PA 19044 DRUG EDUCATIO PA 891330 479536 DIA DIA GLOBAL HEALTHCARE LLC 800 ENTERPRISE ROAD SUITE 200 HORSHAM PA 19044 DRUG EDUCATIO PA 53 150053 DIA DIA (INDIA) PRIVATE LIMITED A303 ANDHERI KURLA RD MAROL ANDHERI MUMBAI India IN 400 059 DRUG RESEARCH IN DIA INC PRIVATE LC 378346 111404 1.00000 DIA EUROPE GMBH Elisabethenanlage 25 Postfach BASEL, Switzerland SZ 4002 DRUG RESEARCH SZ DIA INC LLC 19 29631 1.00000 DIA E-LEARNING EUROPE GMBH Elisabethenanlage 25 Postfach BASEL, Switzerland SZ 4002 E-EDUCATION SZ DIA INC LLC 15 21006 1.00000 false true false false false false false false false true true true false true false true false DIA(INDIA) PRIVATE LIMITED B 51963 DIA GLOBAL HEALTHCARE LLC B 150000